PRA Health Sciences (PRAH) - 5 Year Stock Split History

Historical stock splits for PRA Health Sciences since 2013. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Sector Industry Market Cap Revenue
Medical Medical Services $0.009B $2.259B
PRA Health Sciences, Inc. operates as a global contract research organizations providing outsourced clinical development services to the biotechnology and pharmaceutical industries. It offers therapeutic services in the areas of cardio-metabolic, biosimilars, infectious diseases, immunology, neurology and psychiatry, oncology and hematology, rare diseases, and respiratory needs. The Company engages in bioanalytical laboratory, clinical pharmacology, clinical development, strategic solutions, post marketing research, clinical informatics, clinical diagnostics, and safety and risk management activities. PRA Health Sciences, Inc. is based in Raleigh, North Carolina.
Stock Name Country Market Cap PE Ratio
Express Scripts Holding (ESRX) United States $43.752B 10.30
ICON (ICLR) Ireland $7.385B 24.78
Charles River Laboratories (CRL) United States $5.770B 22.42
HealthEquity (HQY) United States $5.057B 107.25
INC Research Holdings (SYNH) United States $5.000B 22.01
Premier (PINC) United States $4.939B 19.98
Teladoc (TDOC) United States $4.310B 0.00
NovoCure (NVCR) Jersey $3.311B 0.00
AMN Healthcare Services Inc (AMN) United States $2.893B 22.06
Intrexon (XON) United States $1.855B 0.00
BioTelemetry (BEAT) United States $1.640B 45.46
Medpace Holdings (MEDP) United States $1.638B 26.05
IKang Healthcare (KANG) China $1.421B 78.73
Healthways (TVTY) United States $1.380B 19.55
Natera (NTRA) United States $1.247B 0.00
China Cord Blood (CO) China $1.009B 27.00
Apollo Medical Holdings (AMEH) United States $0.850B 0.00
Surgery Partners (SGRY) United States $0.692B 0.00
Civitas Solutions (CIVI) United States $0.590B 15.05
CareDx (CDNA) United States $0.442B 0.00
OncoCyte (OCX) United States $0.118B 0.00
Interpace Diagnostics (IDXG) United States $0.028B 0.00
Cancer Genetics (CGIX) United States $0.025B 0.00
Biocept (BIOC) United States $0.014B 0.00
OpGen (OPGN) United States $0.012B 0.00
FORM Holdings (XSPA) United States $0.009B 0.00